As one of the top scoring companies of the ENTENTE-Life Sciences Investment Forum, Curavac took part in the European Venture Contest and the European Venture Summit, the final event of the European Venture Contest, taking place on December 9th& 10th in Dusseldorf, Germany.
See the list of the top 25% of companies here:
Myasterix partner, Curavac, was among the 8 companies that received a prize for best presentation at ENTENTE.
Curavac was one of the 28 companies selected from a pool of 100 to present at the event. Their prize has qualified them to present at the European Venture Summit in Dusseldorf, Germany on the 8-9 December 2014.
Curavac, Scientific coordinator of Myasterix, was one of the 28 companies selected among 100 companies to present at ENTENTE which took place in Brussels on the 8-9 October during the European Biotechnology Week 2014.
The Myasterix Annual Meeting was held in Graz, Austria on the 26-27 September 2014.
All partners were represented and members of the Independant Advisory Board and Ethics Operational Board participated.
The meeting was hosted by PiChem.